Cite
HARVARD Citation
Sinha, P. et al. (2020). Early administration of interleukin-6 inhibitors for patients with severe COVID-19 disease is associated with decreased intubation, reduced mortality, and increased discharge. International journal of infectious diseases. pp. 28-33. [Online].